Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Response-guided long-term treatment of chronic hepatitis D patients with bulevirtide-results of a "real world" study.
Jachs M, Schwarz C, Panzer M, Binter T, Aberle SW, Hartl L, Dax K, Aigner E, Stättermayer AF, Munda P, Graziadei I, Holzmann H, Trauner M, Zoller H, Gschwantler M, Mandorfer M, Reiberger T, Ferenci P. Jachs M, et al. Among authors: gschwantler m. Aliment Pharmacol Ther. 2022 Jul;56(1):144-154. doi: 10.1111/apt.16945. Epub 2022 May 5. Aliment Pharmacol Ther. 2022. PMID: 35514008 Free PMC article.
Durability of SVR in chronic hepatitis C patients treated with peginterferon-α2a/ribavirin in combination with a direct-acting anti-viral.
Rutter K, Hofer H, Beinhardt S, Dulic M, Gschwantler M, Maieron A, Laferl H, Stättermayer AF, Scherzer TM, Strassl R, Holzmann H, Steindl-Munda P, Ferenci P. Rutter K, et al. Among authors: gschwantler m. Aliment Pharmacol Ther. 2013 Jul;38(2):118-23. doi: 10.1111/apt.12350. Epub 2013 May 26. Aliment Pharmacol Ther. 2013. PMID: 23710895 Free article.
Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C.
Stättermayer AF, Strassl R, Maieron A, Rutter K, Stauber R, Strasser M, Beinhardt S, Datz C, Scherzer TM, Steindl-Munda P, Gschwantler M, Trauner M, Hofer H, Ferenci P. Stättermayer AF, et al. Among authors: gschwantler m. Aliment Pharmacol Ther. 2014 Jan;39(1):104-11. doi: 10.1111/apt.12547. Epub 2013 Nov 10. Aliment Pharmacol Ther. 2014. PMID: 24205831 Free article.
Follow-up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin-free treatment.
Kozbial K, Moser S, Al-Zoairy R, Schwarzer R, Datz C, Stauber R, Laferl H, Strasser M, Beinhardt S, Stättermayer AF, Gschwantler M, Zoller H, Maieron A, Graziadei I, Trauner M, Steindl-Munda P, Hofer H, Ferenci P. Kozbial K, et al. Among authors: gschwantler m. Liver Int. 2018 Jun;38(6):1028-1035. doi: 10.1111/liv.13629. Epub 2017 Dec 1. Liver Int. 2018. PMID: 29136329
Epidemiological trends of HBV and HDV coinfection among Viennese HIV+ patients.
Schmidbauer C, Chromy D, Schmidbauer VU, Schwarz M, Jachs M, Bauer DJM, Binter T, Apata M, Nguyen DT, Mandorfer M, Simbrunner B, Rieger A, Mayer F, Breuer M, Strassl R, Schmidt R, Holzmann H, Trauner M, Gschwantler M, Reiberger T. Schmidbauer C, et al. Among authors: gschwantler m. Liver Int. 2021 Nov;41(11):2622-2634. doi: 10.1111/liv.15018. Epub 2021 Aug 5. Liver Int. 2021. PMID: 34268869 Free PMC article.
Direct patient-physician communication via a hepatitis C hotline facilitates treatment initiation in patients with poor adherence.
Steininger L, Chromy D, Bauer D, Simbrunner B, Binter T, Schwabl P, Schmidbauer C, Trauner M, Gschwantler M, Mandorfer M, Reiberger T. Steininger L, et al. Among authors: gschwantler m. Wien Klin Wochenschr. 2021 May;133(9-10):452-460. doi: 10.1007/s00508-020-01790-y. Epub 2020 Dec 22. Wien Klin Wochenschr. 2021. PMID: 33351152 Free PMC article.
Outcomes of an HCV elimination program targeting the Viennese MSM population.
Jachs M, Binter T, Chromy D, Schalk H, Pichler K, Bauer D, Simbrunner B, Hartl L, Schmidbauer C, Mayer F, Strassl R, Mandorfer M, Gschwantler M, Reiberger T. Jachs M, et al. Among authors: gschwantler m. Wien Klin Wochenschr. 2021 Jul;133(13-14):635-640. doi: 10.1007/s00508-021-01898-9. Epub 2021 Jun 28. Wien Klin Wochenschr. 2021. PMID: 34181068 Free PMC article.
HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease.
Semmler G, Meyer EL, Kozbial K, Schwabl P, Hametner-Schreil S, Zanetto A, Bauer D, Chromy D, Simbrunner B, Scheiner B, Stättermayer AF, Pinter M, Schöfl R, Russo FP, Greenfield H, Schwarz M, Schwarz C, Gschwantler M, Alonso López S, Manzano ML, Ahumada A, Bañares R, Pons M, Rodríguez-Tajes S, Genescà J, Lens S, Trauner M, Ferenci P, Reiberger T, Mandorfer M. Semmler G, et al. Among authors: gschwantler m. J Hepatol. 2022 Apr;76(4):812-821. doi: 10.1016/j.jhep.2021.11.025. Epub 2021 Dec 3. J Hepatol. 2022. PMID: 34871626 Free article.
Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis.
Jachs M, Binter T, Schmidbauer C, Hartl L, Strasser M, Laferl H, Hametner-Schreil S, Lindorfer A, Dax K, Stauber RE, Kessler HH, Bernhofer S, Maieron A, Loacker L, Bota S, Santonja I, Munda P, Mandorfer M, Peck-Radosavljevic M, Holzmann H, Gschwantler M, Zoller H, Ferenci P, Reiberger T. Jachs M, et al. Among authors: gschwantler m. United European Gastroenterol J. 2021 Dec;9(10):1119-1127. doi: 10.1002/ueg2.12163. Epub 2021 Dec 7. United European Gastroenterol J. 2021. PMID: 34873866 Free PMC article.
The 'Viennese epidemic' of acute HCV in the era of direct-acting antivirals.
Chromy D, Bauer DJM, Simbrunner B, Jachs M, Hartl L, Schwabl P, Schwarz C, Rieger A, Grabmeier-Pfistershammer K, Trauner M, Ferenci P, Mandorfer M, Gschwantler M, Reiberger T. Chromy D, et al. Among authors: gschwantler m. J Viral Hepat. 2022 May;29(5):385-394. doi: 10.1111/jvh.13665. Epub 2022 Mar 15. J Viral Hepat. 2022. PMID: 35274399 Free PMC article.
135 results